Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Maturitas(9)
Área temáticas
Enfermedades(4)
Salud y seguridad personal(4)
Fisiología humana(2)
Medicina y salud(2)
Farmacología y terapéutica(1)
Origen
scopus(9)
A model of care for healthy menopause and ageing: EMAS position statement
ArticleAbstract: Worldwide, the number of menopausal women is increasing. They present with complex medical issues thPalabras claves:EMAS, Healthcare model, Healthy menopause, Holistic, Women's healthAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., van der Schouw Y.T.Fuentes:scopusCurrent management of pelvic organ prolapse in aging women: EMAS clinical guide
ArticleAbstract: Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women arePalabras claves:aging, management, Pelvic organ prolapse, Urinary incontinenceAutores:Cano A., Giannini A., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Russo E., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.Fuentes:scopusEMAS position statement: Pbkp_redictors of premature and early natural menopause
ArticleAbstract: Introduction: While the associations of genetic, reproductive and environmental factors with the timPalabras claves:Aetiology, Early menopause, Premature ovarian insufficiency, RISK FACTORSAutores:Cano A., Chung H.F., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.Fuentes:scopusEMAS position statement: Testosterone replacement therapy in the aging male
ArticleAbstract: Introduction Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, charaPalabras claves:Aging male, Late-onset hypogonadism, Testosterone replacementAutores:Ceausu I., Depypere H., Dimopoulou C., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simonsini T., Stevenson J.C., Stute P., van der Schouw Y.T.Fuentes:scopusOsteoporosis management in patients with breast cancer: EMAS position statement
ReviewAbstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrogPalabras claves:adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screeningAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusMaintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)
ArticleAbstract: This position statement from the European Menopause and Andropause Society (EMAS) provides a care paPalabras claves:genitourinary syndrome of menopause, hormone therapy, Hot Flushes, MENOPAUSE, OSTEOPOROSIS, WomenAutores:Armeni E., Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Schouw Y.T.V.D., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.Fuentes:scopusManagement of depressive symptoms in peri- and postmenopausal women: EMAS position statement
ArticleAbstract: Introduction: Globally, the total number of people with depression exceeds 300 million, and the inciPalabras claves:Depression, Early menopause, EMAS, menopausal hormone therapy, Menopausal transition, Model of care, PERIMENOPAUSEAutores:Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Karageorgiou V., Kiesel L., Lambrinoudaki I., Lindén Hirschberg A., Lopes P., Peter A. Chedraui, Pines A., Rees M., Spyropoulou A., Stute P., van Trotsenburg M., Zervas I.Fuentes:scopusInterventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement
ReviewAbstract: Background Ovarian cancer is a leading cause of female gynecological cancer-related death, and therePalabras claves:bilateral oophorectomy, Bilateral salpingectomy, BRCA gene mutation, Combined oral contraceptives, Fallopian tubes cancer, hysterectomy, Non-steroid anti-inflammatory drugs, obesity, Ovarian borderline tumors, Ovarian Cancer, smokingAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Kehoe S., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.Fuentes:scopusMenopause and diabetes: EMAS clinical guide
ArticleAbstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independentlyPalabras claves:menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitusAutores:Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.Fuentes:scopus